Cost-effectiveness analysis of intradiscal condoliase injection vs. surgical or conservative treatment for lumbar disc herniation

被引:7
|
作者
Takaki, Shu [1 ,3 ]
Miyama, Hiroshi [1 ]
Iwasaki, Motoki [2 ]
机构
[1] Kaken Pharmaceut Co Ltd, Med Affairs Dept, Tokyo, Japan
[2] Osaka Rosai Hosp, Dept Orthopaed Surg, Osaka, Japan
[3] Kaken Pharmaceut Co Ltd, Med Affairs Dept, 28-8,Honkomagome 2 chome,Bunkyo ku, Tokyo 1138650, Japan
关键词
Cost analysis; intradiscal enzyme injection; lumber disc herniation; condoliase;
D O I
10.1080/13696998.2023.2173465
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims This study aimed to analyze the cost-effectiveness of intradiscal condoliase injection compared to surgical or conservative treatment for patients with lumbar disc herniation (LDH) who are refractory to conservative treatment. Methods We performed the following cost-effectiveness analyses: (I) condoliase followed by open surgery (for non-responders to condoliase) vs. open surgery from the beginning, (II) condoliase followed by endoscopic surgery (for non-responders to condoliase) vs. endoscopic surgery from the beginning, and (III) condoliase + conservative treatment vs. conservative treatment. In the first two comparisons with surgical treatments, we assumed that utilities were equal in both groups and estimated the tangible (treatment, adverse events, postoperative follow-up) and intangible (mental and physical burden, and productivity loss) costs based on the existing literature, the medical expense scoring table, and online questionnaire. In the last comparison without surgical treatment, we estimated the incremental cost-effectiveness. Results The average cost per patient of condoliase followed by open surgery (for non-responders to condoliase) was 701,643 yen, with a reduction of 663,369 in comparison to that of open surgery from the beginning (1,365,012 yen). The average cost per patient of condoliase followed by endoscopic surgery (for non-responders to condoliase) was 643,909 yen, with a reduction of 514,909 in comparison to that of endoscopic surgery from the beginning (1,158,817 yen). ICER was 1.58 million yen/QALY (Delta QALY = 0.119, 95% confidence interval: 0.059-0.180; Delta cost = 188,809 yen at 2 years post-treatment). Conclusions Condoliase as a first line treatment option ahead of surgical treatment for LDH is superior, from a cost perspective, to surgical treatment from the beginning. Condoliase is also a cost-effective alternative to non-surgery conservative treatment.
引用
收藏
页码:233 / 242
页数:10
相关论文
共 50 条
  • [41] Transabdominal cerclage vs. vaginal cerclage: a cost-effectiveness analysis
    Chaiken, Sarina R.
    Schmidt, Eleanor M.
    Susich, Marguerite
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S434 - S435
  • [42] COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VS. SECUKINUMAB IN SEQUENTIAL BIOLOGIC TREATMENT OF PSORIASIS IN THE UK
    Johansson, E.
    Svedbom, A.
    Kumar, G.
    Hartz, S.
    Kiri, S.
    VALUE IN HEALTH, 2016, 19 (07) : A568 - A568
  • [43] Cost-effectiveness Analysis of Office vs. Home Biofeedback in the Treatment of Dyssynergic Defecation (DD)
    Go, Jorge
    Brown, Kice
    Schneider, John
    Paulson, Jessica
    Rao, Satish
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S488 - S488
  • [44] Cost-effectiveness of treatment of superficial basal cell carcinoma:: surgical excision vs. imiquimod 5% cream
    Vanaclocha, F.
    Dauden, E.
    Badia, X.
    Guillen, C.
    Conejo-Mir, J. S.
    de Los Terreros, M. Sainz
    Hamel, L.
    Llorens, M. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (04) : 769 - 771
  • [45] Effectiveness of Surgical Treatment for Far-lateral Lumbar Disc Herniation: A Single Surgeon's Perspective
    Baykal, Duygu
    Cetiner, Mehmet Ziya
    MEDICAL JOURNAL OF BAKIRKOY, 2024, 20 (03) : 252 - 256
  • [46] COST-EFFECTIVENESS ANALYSIS OF EXTENDED CONSERVATIVE THERAPY VERSUS SURGICAL INTERVENTION IN THE MANAGEMENT OF HERNIATED LUMBAR INTERVERTEBRAL-DISK
    SHVARTZMAN, L
    WEINGARTEN, E
    SHERRY, H
    LEVIN, S
    PERSAUD, A
    SPINE, 1992, 17 (02) : 176 - 182
  • [47] Dermatologists vs. family physicians: Cost-effectiveness in the treatment of psoriasis.
    Toy, BR
    Spellman, MC
    Goltz, RW
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 76A - 76A
  • [48] The cost-effectiveness of budesonide vs. sodium cromoglycate in the treatment of asthmatic children
    Andersson, F
    Kjellman, M
    Forsberg, G
    Möller, C
    Arheden, L
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A760 - A760
  • [49] COST-EFFECTIVENESS OF TIMELY ENDOVASCULAR INTERVENTION VS. DELAYED INTERVENTION BY CONSERVATIVE TREATMENT IN PATIENTS WITH CRITICAL LIMB ISCHEMIA (CLI)
    Vadia, R.
    VALUE IN HEALTH, 2020, 23 : S582 - S582
  • [50] Cost-Effectiveness Analysis of Azathioprine vs. Infliximab vs. Combination Therapy for Crohn's Disease
    Reinink, Andrew R.
    Gregory, Martin
    Kymes, Steven
    Dassopoulos, Themistocles
    GASTROENTEROLOGY, 2011, 140 (05) : S175 - S176